logo

ESTA

Establishment Labs·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 4
Bearish signal 1
Consensus Rating "Strong Buy"
Ample Liquidity
High Gross Profit Margin
Revenue Beats Expectation
EPS Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000

About ESTA

Establishment Labs Holdings Inc.

A medical technology company focused on women's health, initially in the breast aesthetics and reconstruction market

Healthcare Providers and Services
10/09/2013
07/19/2018
NASDAQ Stock Exchange
1,023
12-31
Common stock
11401 Century Oaks Terrace Suite 400 Austin Texas 78758
--
Establishment Labs Holdings Inc., was reorganized on October 9, 2013 under the control of the parent company of the British Virgin Islands. The company is a medical technology company dedicated to improving patient safety and aesthetics, initially focusing on the breast aesthetics and reconstruction market. Its silicone filled breast implants under the brand name Motiva Implants are the core product of its medical technology platform. The company has also developed other complementary products and services designed to further improve patient outcomes.

Earnings Call

Company Financials

EPS

ESTA has released its 2025 Q3 earnings. EPS was reported at -0.38, versus the expected -0.51, beating expectations. The chart below visualizes how ESTA has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

ESTA has released its 2025 Q3 earnings report, with revenue of 53.78M, reflecting a YoY change of 33.70%, and net profit of -11.15M, showing a YoY change of 33.19%. The Sankey diagram below clearly presents ESTA's revenue sources and cost distribution.

Forecast

Wall Street Opinions

Price Target

Volume Profile

Trade Flow Insight

Seasonals

Community Forum

Loading...

Related News

No articles available

Related Symbols

You can ask Aime